Myasthenia gravis with a myeloma-type, gamma-G (IgG) immunoglobulin abnormality. 1969

L P Rowland, and E F Osserman, and W B Scharfman, and R F Balsam, and S Ball

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007122 Immunoelectrophoresis A technique that combines protein electrophoresis and double immunodiffusion. In this procedure proteins are first separated by gel electrophoresis (usually agarose), then made visible by immunodiffusion of specific antibodies. A distinct elliptical precipitin arc results for each protein detectable by the antisera.
D008297 Male Males
D008558 Melphalan An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen. Medphalan,Merphalan,Phenylalanine Mustard,Sarcolysine,Sarkolysin,4-(Bis(2-chloroethyl)amino)phenylalanine,Alkeran,L-PAM,Mustard, Phenylalanine
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D001796 Blood Protein Disorders Hematologic diseases caused by structural or functional defects of BLOOD PROTEINS. Blood Protein Disorder,Disorder, Blood Protein,Disorders, Blood Protein,Protein Disorder, Blood,Protein Disorders, Blood
D001797 Blood Protein Electrophoresis Electrophoresis applied to BLOOD PROTEINS. Hemoglobin Electrophoresis,Electrophoresis, Blood Protein,Electrophoresis, Hemoglobin,Protein Electrophoresis, Blood
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L P Rowland, and E F Osserman, and W B Scharfman, and R F Balsam, and S Ball
January 1995, Srpski arhiv za celokupno lekarstvo,
L P Rowland, and E F Osserman, and W B Scharfman, and R F Balsam, and S Ball
April 2002, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology,
L P Rowland, and E F Osserman, and W B Scharfman, and R F Balsam, and S Ball
September 2023, Scandinavian journal of clinical and laboratory investigation,
L P Rowland, and E F Osserman, and W B Scharfman, and R F Balsam, and S Ball
March 1990, Acta neurologica Scandinavica,
L P Rowland, and E F Osserman, and W B Scharfman, and R F Balsam, and S Ball
November 1989, Clinical immunology and immunopathology,
L P Rowland, and E F Osserman, and W B Scharfman, and R F Balsam, and S Ball
January 2003, The Cochrane database of systematic reviews,
L P Rowland, and E F Osserman, and W B Scharfman, and R F Balsam, and S Ball
September 2015, Nihon rinsho. Japanese journal of clinical medicine,
L P Rowland, and E F Osserman, and W B Scharfman, and R F Balsam, and S Ball
December 2012, The Cochrane database of systematic reviews,
L P Rowland, and E F Osserman, and W B Scharfman, and R F Balsam, and S Ball
January 2008, The Cochrane database of systematic reviews,
L P Rowland, and E F Osserman, and W B Scharfman, and R F Balsam, and S Ball
April 2006, The Cochrane database of systematic reviews,
Copied contents to your clipboard!